Non-invasive Approaches to Precision and Personalized Dermatology
Precision Biomarker Platform Technology
DermTech’s platform technology is bringing precision to the practice of dermatology through non-invasive assessment of the skin. Our proprietary technology can be used for biomarker analysis of RNA, DNA, protein, and microbiome.
The Simplicity of the Smart Sticker™
Eliminates need for surgical biopsy and collects 1.5mg of stratum corneum tissue capturing signatures from epidermal keratinocytes, T cells, dendritic cells, melanocytes, etc.
Simple Sample Transport
Sample doesn’t require fixation or refrigeration and preserves genomic and proteomic material from the skin for up to 10 days at room temperature & greater than a year when stored at -80C.
Large Collection Area
Provides 19mm collection area for Lesional and Non-lesional samples.
Precision Biomarker Analysis
Includes Microbiome, Proteomic, Lipidomic, NGS, and targeted DNA/RNA analysis.
The Simplicity of the Smart Sticker™
Eliminates need for surgical biopsy and collects 1.5mg of stratum corneum tissue capturing signatures from epidermal keratinocytes, T cells, dendritic cells, melanocytes, etc.
Large Collection Area
Provides 19mm collection area for Lesional and Non-lesional samples.
Simple Sample Transport
Sample doesn’t require fixation or refrigeration and preserves genomic and proteomic material from the skin for up to 10 days at room temperature & greater than a year when stored at -80C.
Precision Biomarker Analysis
Includes Microbiome, Proteomic, Lipidomic, NGS, and targeted DNA/RNA analysis.
Your translational medicine partner.
The Smart Sticker™ offers the opportunity to non-invasively identify biomarkers of disease and subgroups of disease, stratify patients based on genomic and proteomic profiles, enrich for responders in a population, and predict and track responses to therapeutic intervention.
We offer expert services including:
- Biomarker Identification
- New Target Identification
- Patient Segmentation and Stratification
- Bioinformatics Support
DermTech’s validated platform technology is appropriate for indications where skin is the target or a surrogate target organ and is being used to support drug discovery and development programs focused on cancers and inflammatory diseases in clinical research studies.
Indications Include:
Send us a message
Click the contact us button and drop us a line. We'll be in touch shortly.
Get In Touch
Partner with DermTech today.